Rigel Pharmaceuticals Inc
Ownership
Ownership Structure
Who owns Rigel Pharmaceuticals Inc (RIGL)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 80.2% of the shares are freely tradable; institutional investors hold 94.8%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 10.38 | 1,939,818 | +9.7 | 06/30/2026 |
| Soleus Capital Management, L.P. | 9.87 | 1,843,504 | +18,335.0 | 06/30/2026 |
| Armistice Capital, LLC | 8.95 | 1,672,000 | +30.6 | 06/30/2026 |
| State Street Corp | 5.57 | 1,039,994 | -7.2 | 06/30/2026 |
| Vanguard Capital Management, LLC | 4.20 | 785,107 | +2.7 | 06/30/2026 |
| American Century Companies Inc | 3.97 | 741,718 | +36.2 | 06/30/2026 |
| LSV Asset Management | 3.86 | 721,666 | +20.0 | 06/30/2026 |
| Acadian Asset Management LLC | 3.17 | 591,686 | -11.2 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Avantis US Small Cap Value ETF | 4.67 | 871,530 | +0.3 | 09/30/2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 2.98 | 555,846 | +0.0 | 09/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Rodriguez Raul R | CEO, President | 273,362 | 13,367,402 $ | Sep 1, 2026 | direct |
| Schorno Dean L | EVP & Chief Financial Officer | 82,962 | 4,056,842 $ | Sep 2, 2026 | direct |
| Santos David A | EVP, Chief Commercial Officer | 61,622 | 3,013,316 $ | Sep 1, 2026 | direct |
| Furey Raymond J. | EVP, GC, CCO & Corp Sec | 50,559 | 2,472,335 $ | Sep 1, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 2, 2026 | Schorno Dean L | EVP & Chief Financial Officer | Other | 1,286 | 24.20 | 31,121 |
| Sep 2, 2026 | Schorno Dean L | EVP & Chief Financial Officer | Other | 2,000 | 24.20 | 48,400 |
| Sep 2, 2026 | Schorno Dean L | EVP & Chief Financial Officer | Other | 620 | 18.70 | 11,594 |
| Sep 2, 2026 | Schorno Dean L | EVP & Chief Financial Officer | Other | 694 | 12.70 | 8,814 |
| Sep 1, 2026 | Schorno Dean L | EVP & Chief Financial Officer | Other | 928 | 47.50 | 44,080 |
| Sep 1, 2026 | Santos David A | EVP, Chief Commercial Officer | Other | 874 | 47.50 | 41,515 |
| Sep 1, 2026 | Rodriguez Raul R | CEO, President | Other | 2,424 | 47.50 | 115,140 |
| Sep 1, 2026 | Furey Raymond J. | EVP, GC, CCO & Corp Sec | Other | 877 | 47.50 | 41,658 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: November 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.